Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Multi-centre, Post-marketing Study to Evaluate the Incidence and Aetiology of Reoperations With Allergan Natrelle® Breast Implants in Primary Augmentation (RANBI)

NCT02132572 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02132572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02132572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Multi-centre, Post-marketing Study to Evaluate the Incidence and Aetiology of Reoperations With Allergan Natrelle® Breast Implants in Primary Augmentation (RANBI)
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
October 31, 2014
Enrollment
201 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast implantation